INS and Hypoglycemia: The most recently published RCT evaluated the effectiveness of technosphere insulin with insulin lispro, and found that HbA1c was unchanged in both groups, however, the technosphere insulin was associated with improved post-meal glucose and a lower risk of hypoglycemia in a 16-week period [25].